Article info
PDFOriginal article
The impact of patient factors on use of antifungal medicines in adults with life-threatening illness: a cross-sectional study in 34 English hospitals
- Correspondence to Peter Stephens, IMS HEALTH, 210 Pentonville Road, London, N1 9JY, UK and WHO Collaborating Centre for Pharmacoepidemiology and Pharmaceutical Policy Analysis, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht 3508 TB, The Netherlands; pstephens{at}uk.imshealth.com
Citation
The impact of patient factors on use of antifungal medicines in adults with life-threatening illness: a cross-sectional study in 34 English hospitals
Publication history
- Received April 14, 2014
- Revised June 30, 2014
- Accepted July 15, 2014
- First published August 1, 2014.
Online issue publication
May 13, 2016
Article Versions
- Previous version (13 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions